Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP439477.RApettZns_00TTY_N_-xUmQWzjD7OxtEzRp6qzlqf4ojk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP439477.RApettZns_00TTY_N_-xUmQWzjD7OxtEzRp6qzlqf4ojk130_assertion type Assertion NP439477.RApettZns_00TTY_N_-xUmQWzjD7OxtEzRp6qzlqf4ojk130_head.
- NP439477.RApettZns_00TTY_N_-xUmQWzjD7OxtEzRp6qzlqf4ojk130_assertion description "[Although mutations of the corresponding genes are rare events in SFT, PDGFR-alpha/beta, and hepatocyte growth factor receptor tyrosine kinases should be further investigated given the availability of specific inhibitory molecules which might provide useful and novel therapeutical approaches for SFT patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP439477.RApettZns_00TTY_N_-xUmQWzjD7OxtEzRp6qzlqf4ojk130_provenance.
- NP439477.RApettZns_00TTY_N_-xUmQWzjD7OxtEzRp6qzlqf4ojk130_assertion evidence source_evidence_literature NP439477.RApettZns_00TTY_N_-xUmQWzjD7OxtEzRp6qzlqf4ojk130_provenance.
- NP439477.RApettZns_00TTY_N_-xUmQWzjD7OxtEzRp6qzlqf4ojk130_assertion SIO_000772 18753943 NP439477.RApettZns_00TTY_N_-xUmQWzjD7OxtEzRp6qzlqf4ojk130_provenance.
- NP439477.RApettZns_00TTY_N_-xUmQWzjD7OxtEzRp6qzlqf4ojk130_assertion wasDerivedFrom befree-20140225 NP439477.RApettZns_00TTY_N_-xUmQWzjD7OxtEzRp6qzlqf4ojk130_provenance.
- NP439477.RApettZns_00TTY_N_-xUmQWzjD7OxtEzRp6qzlqf4ojk130_assertion wasGeneratedBy ECO_0000203 NP439477.RApettZns_00TTY_N_-xUmQWzjD7OxtEzRp6qzlqf4ojk130_provenance.